as of 12-15-2025 3:28pm EST
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
| Founded: | 1983 | Country: | United States |
| Employees: | N/A | City: | BURLINGTON |
| Market Cap: | 1.9B | IPO Year: | 2006 |
| Target Price: | $101.83 | AVG Volume (30 days): | 188.5K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 2.32 | EPS Growth: | 27.40 |
| 52 Week Low/High: | $71.42 - $105.55 | Next Earning Date: | 11-06-2025 |
| Revenue: | $240,866,000 | Revenue Growth: | 13.07% |
| Revenue Growth (this year): | 15.17% | Revenue Growth (next year): | 9.07% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
See how LMAT stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "LMAT LeMaitre Vascular Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.